Amyloidosis Management in 2025: Current and Future Therapies

Learning Objectives: 

By the end of this webinar, participants will be able to: 

• Describe the mechanisms in cardiac amyloidosis contributing to heart failure.  

• Apply evidence-based management strategies to optimize patient outcomes.  

• Evaluate current pharmacologic therapies for amyloidosis, including the roles of stabilizers and silencers. 

• Discuss emerging clinical evidence and novel therapies to assess their impact on the evolving landscape of amyloidosis management.